Fundraising FoxCortado Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Cadenza Bio develops small-molecule drugs for oral administration to treat demyelinating and inflammatory diseases.
BiotechFemTechMedical DevicesYukon, US
Carol Curtis, PhD(Chief Executive Officer, Founder)Elaine Hamm, PhD(Chief Operating Officer, Founder)John Katzenellenbogen, PhD(Scientific Founder)Seema Tiwari-Woodruff, PhD(Scientific Founder)Elaine Hamm(Executive Officer, Director)Carol Curtis(Executive Officer, Director)in
Co-investorsIllinois VenturesOklahoma Life SciencePlains VenturesSmartHealth Catalyzer
Moove.ai applies machine learning to real-time connected vehicle data to assess transportation risk and build mitigation tools focused on road safety and efficiency.
AI & Machine LearningData & InfrastructureMobility & TransportationLafayette, US
Rafay KhaninJack Greco(Director)inSalman Dhanani(Director)Abdur Rafay Khan(Executive Officer, Director)
BoardLauren Deluca(Director)in
Co-investorsDolby Family VenturesMotivate Venture CapitalService Provider CapitalUber
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.